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Abstract
Background: Ketorolac tromethamine is a versatile analgesic drug used extensively for the treatment of fever and
moderate to severe pain. It is a potent non-steroidal anti-inflammatory drug that extends opioid-level analgesia to
patients. Two new selective methods are proposed for spectrophotometric determination of ketorolac tromethamine
(KT) in pure and pharmaceutical formulation.
Methods: The determination procedures are based on the condensation reaction of KT with 2,4-dinitrophenylhydrazine
(DNPH) in strongly alkaline medium resulting in the formation of red-colored hydrazones which is quantitated
at 424 nm for method A and method B involves the charge transfer reaction between KT as electron donor
and 7,7′,8,8′-tetracyanoquinodimethane (TCNQ) as π-acceptor to form dark green-colored complex which is
measured at 842 nm.
Results: Linear correlation is obtained in the range 0.50–18.50 μg mL−1 and 2.00–50.00 μg mL−1 with detection limits
of 0.1579 and 0.3721 μg mL−1 for method A and method B, respectively. The optimum analytical conditions are
analyzed, and the proposed assay is validated as per the ICH guidelines.
Conclusions: The developed methods are effectively applied to the determination of KT in tablets, injections, and
ophthalmic formulations with good percentage recoveries. The final reaction products are characterized by spectral
analysis (FT-IR and 1H NMR). In addition, the surface morphology of the reaction products are also studied using
scanning electron microscopy.
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Background
Ketorolac tromethamine (KT) is a non-steroidal anti-
inflammatory drug (NSAID) which is widely used as non-
narcotic substitute to opioid analgesics. It belongs to a class
of heterocyclic acid derivatives with chemical name, (±)-5-
benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid and
2-amino-2-(hydroxymethyl)-1,3-propanediol (Fig. 1). KT is
a prostaglandin synthetase-inhibiting analgesic with rapid
onset of action and prolonged efficacy in the short-term
management of acute pain (Resman-Targoff 1990; Stanski
et al. 1990). It has also been indicated in ameliorating
severe postoperative pain related with abdominal, gyneco-
logic, oral, and orthopedic surgery (Litvak and McEvoy
1990). Unlike opiate analgesics, KT is well tolerated with
diminished rates of opioid-induced adverse events making
it an effective alternative for reducing ocular inflammation
and for the symptomatic relief of acute renal colic, pain
associated with trauma, and visceral pain associated with
cancer (Litvak and McEvoy 1990; Brown et al. 1990). The
desired anti-inflammatory effect is due to the reduction in
formation of precursors of prostaglandin which is believed
to be caused by the inhibition of both cyclooxygenase-1
(COX-1) and cyclooxygenase-2 (COX-2) enzymes. The
resultant decrease in prostaglandin activity effectively* Correspondence: nbadiadka@yahoo.co.uk
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blocks the generation of pain impulse, thereby contributing
to the analgesic effect of this medication (Blais et al. 2002).
KT is an off-white crystalline powder freely soluble in
methanol, and it exists in the anionic form, in particular,
at physiological pH. It is a racemate of [−]S- and [+]R-
enantiomeric forms, with the S-form exhibiting the
therapeutic activity. To enhance the water solubility and
render the drug fairly appropriate for parenteral admin-
istration (Buckley and Brogden 1990), it is formulated as
tromethamine salt and administered intramuscularly,
intravenously, as a topical ophthalmic solution and also
orally as a continuation therapy to injection (Sinha et al.
2009). The analgesic efficacy of KT appears to be super-
ior to morphine or meperidine because it lacks the de-
pressant effects of opioids. Because of its enhanced
importance over morphine, it is widely preferred as an
analgesic drug over opiate comparators in controlling
postsurgical pain [DeAndrade et al. 1994].
The great clinical significance of KT in medicinal field
has led to an extensive literature on its determination in
pharmaceutical formulation. A survey of literature re-
vealed that the KT has been analyzed in pharmaceutical
preparations either alone or in combination with other
drugs by HPLC (Kumaraswamy et al. 2012; Razzaq et al.
2012; Tsvetkova et al. 2012; Dave et al. 2013; Dubey
et al. 2012), HPTLC (Devarajan et al. 2000; Vandana
et al. 2013), voltammetry (Squella et al. 1997), and mi-
cellar electrokinetic chromatography (Orlandini et al.
2004). Though these analytical procedures are sensitive,
it entails a disadvantage of not being simple and requir-
ing sophisticated experimental setup, increased cost of
analysis and high consumption of solvents by the mobile
phase for the chromatographic techniques. Therefore, it
is essential to develop simple, rapid, and reproducible
methods that can be adapted for routine analysis of KT
in quality control laboratories. In recent times, spectro-
photometry has been successfully employed as a quanti-
tative technique for the determination of drugs in bulk
and formulations.
Derivative spectrophotometric methods (Jitendra et al.
2009; Yatri et al. 2013; Ramzia et al. 2013) and quite a
few visible spectrophotometric methods (Rajasekaran
1995; Pratapareddy and Chakravarthi 2012; Kamath
et al. 1994; Arshiya et al. 2012; Dattaray and Uday 1997;
Sawsan et al. 2013) are reported in literature for
quantitative determination of KT in bulk and dosage
forms. The purpose of this study is to develop simple,
accurate, and economical methods for the determin-
ation of KT using 2,4-dinitrophenylhydrazine (DNPH)
and 7,7′,8,8′-tetracyanoquinodimethane (TCNQ) as
reagents. Optimization of various experimental condi-
tions, stoichiometry, and mechanism of the proposed
reactions are studied. The suggested methods have
high sensitivity and are validated as per ICH guide-
lines and rely on the use of non-expensive technique
and affordable easily available chemicals. The applica-
tion of the proposed methods is explored by employ-
ing these methods for the microdetermination of KT
in its pharmaceutical dosage forms. Attempts have
also been made to synthesize and characterize the
reaction products using spectroscopic techniques.
Methods
Instrumentation and physical measurements
Spectrophotometric measurements were performed on
SHIMADZU UV-2550 double beam spectrophotometer
equipped with 1-cm matched quartz cells. The infrared
spectra within the range of 4000–400 cm−1 for the free
reactants and the reaction products were recorded using
KBr disc on SHIMADZU FT-IR-Prestige-21 spectrom-
eter. 1H NMR spectra (400 MHz) were recorded on
AV400 spectrometer using DMSO-d6 as a solvent and
TMS as the internal reference standard. Scanning elec-
tron microscopy (SEM) images were taken in Zeiss
Sigma instrument equipped with GEMINI column, with
an accelerating voltage of 2.00 kV.
Materials and reagents
Pure sample of ketorolac tromethamine (KT) was
provided by CAD Pharma Inc., Bangalore, India. The
following pharmaceutical formulations were procured
from commercial source: Ketorol™ tablets (Dr. Reddy’s
Laboratories Ltd., India) labeled to contain 10 mg of
ketorolac tromethamine per tablet, Ketorol™ vials (Dr.
Reddy’s Laboratories Ltd., India) labeled to contain
30 mg of ketorolac tromethamine in 1 mL of sterile
solution, and Ketlur® sterile ophthalmic solution (Sun
Pharmaceutical Industries Ltd., India) labeled to con-
tain 5 mg of ketorolac tromethamine per milliliter of
aqueous solution.
Analytical reagent grade 2,4-dinitrophenylhydrazine
and potassium hydroxide were purchased from BDH
chemicals. The reagent 7,7′,8,8′-tetracyanoquinodimethane
was obtained from Sigma-Aldrich. Spectroscopic grade
methanol and acetonitrile solvents were supplied by
Spectrochem.
Fig. 1 Chemical structure of ketorolac tromethamine
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Preparation of standard stock and reagent solutions
The stock standard solutions of KT (100 μg mL−1) were
prepared by dissolving precisely weighed 10 mg of pure
drug in 100 mL of methanol and acetonitrile for method
A and method B, respectively. The working concentra-
tions were prepared by approximate dilution of standard
drug solution.
The reagent solution of DNPH was prepared at a con-
centration of 5 × 10−3 M in methanol, and TCNQ was
prepared at a concentration of 5 × 10−4 M in acetonitrile
solvent. The stock solutions were freshly prepared and
protected from light.
General analytical procedures
Determination of KT based on the measurement of Schiff
base (method A)
Aliquots containing 0.50–18.50 μg mL−1 of standard KT
(100 μg mL−1) were transferred quantitatively to 10 mL
calibrated standard flasks. To that, 1 mL of DNPH solu-
tion was added followed by addition of 1 mL of 2 N
methanolic potassium hydroxide and the volume was
brought to 5 mL with methanol. The solutions were in-
cubated in water bath at 60 °C for 15 min. The solutions
were cooled to room temperature and diluted up to the
mark using methanol, and absorbances were measured
at 424 nm against the reagent blank.
Determination of KT based on the measurement of charge
transfer (method B)
Aliquots containing 2.00–50.00 μg mL−1 of standard KT
(100 μg mL−1) were transferred quantitatively to 10 mL
calibrated standard flasks. To each flask, 2 mL of TCNQ
was added and the reaction mixture was heated at 50 °C
for 10 min. The solutions were then cooled and com-
pleted to the volume with acetonitrile solvent, and
absorbances were measured at 842 nm against the
reagent blank.
Analysis of pharmaceutical formulation
Tablets
The contents of 20 tablets were pulverized to fine pow-
der, and an amount equivalent to 10 mg was accurately
weighed and dissolved in 50 mL methanol and aceto-
nitrile for method A and B, respectively. The solutions
were swirled for 10 min and filtered through Whatmann
No. 40 filter paper into two separate 100-mL standard
flasks which was then diluted to the mark with respect-
ive solvents. A convenient aliquot from the resulting
solutions was then subjected to analysis.
Injection vials
The contents of two injection vials, each having an
amount equivalent to 30 mg of active ingredient was fil-
tered through Whatmann No. 40 filter paper and
transferred into two separate 100-mL calibrated flask. It
was then dissolved with methanol and acetonitrile for
method A and B, respectively. The solutions were mixed
well and completed to the volume with respective sol-
vents. A convenient aliquot from resulting solutions was
then subjected to analysis.
Ophthalmic solutions
An accurately measured volume equivalent to 5 mg was
dissolved in 25 mL methanol and acetonitrile for method
A and B, respectively. The solutions were then mixed
well and filtered through Whatmann No. 40 filter paper.
The filtrates were collected in two separate 50-mL cali-
brated flasks and diluted to the mark with respective sol-
vents. A convenient aliquot from resulting solutions was
then subjected to analysis.
Synthesis of solid reaction products
The synthesis of KT-DNPH product was done by reflux-
ing a mixture of KT (1 mmol, 0.3764 g) and DNPH
(1 mmol, 0.1981 g) in 50 mL of methanol in basic
medium for 4 h. The reaction mixture was allowed to
cool and filtered to obtain red-colored solid precipitate,
which was then washed with cold water and recrystal-
lized from acetonitrile solvent. The solid charge transfer
complex KT-TCNQ was synthesized by mixing an equi-
molar concentration of KT (0.50 mmol, 0.1882 g) and
TCNQ (0.50 mmol, 0.1020 g) in 40 mL of acetonitrile,
and the mixture was stirred well at room temperature
for half an hour. The product was then filtered, washed
with acetonitrile, and dried.
Results and discussion
The reaction of carbonyl functionality with DNPH is the
most popular and widely studied for the quantitative
measurement of trace quantities of carbonyl content in
variety of organic mixtures (Dasgupta et al. 1994). The
keto group of the drug KT is condensed with DNPH to
form 2,4-dinitrophenylhydrazone, and in strongly alka-
line conditions, the hydrazones form wine red-colored
product of quinonoid structure (Dasgupta et al. 1994)
showing maximum absorption at 424 nm. This forms
the basis of measurement principle for the determination
of KT by method A. The second method B involves
exploring the charge transfer reaction of KT with TCNQ.
The tertiary nitrogen atom present in the pyrrolizine
moiety acts as the electron donor, donating electrons
to π-acceptors like TCNQ to form deep green-colored
complex which absorbs maximally at 842 nm. The
electronic absorption spectra of KT and its reaction
products are shown in Fig. 2, and the probable reac-
tion mechanism is depicted in Fig. 3.
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Fig. 2 Electronic absorption spectra of a pure KT, b KT-DNPH, and c KT-TCNQ
Fig. 3 Probable reaction mechanisms for the proposed methods
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Optimization of reaction parameters
In order to achieve maximum sensitivity and selectivity,
the proposed spectrophotometric methods are optimized
by carefully studying the different reaction variables
affecting the reaction. The optimum experimental condi-
tions are established by studying the influence of one
parameter on the absorbance values of colored species
and in turn keeping the other parameter constant.
Effect of solvent
The effect of different solvents like methanol, ethanol,
acetone, acetonitrile, water, and 1,4-dioxane has been
studied for the proposed methods (Fig. 4). For method
A, diluting with methanol gave the highest color inten-
sity of Schiff base product and thus it is chosen as the
ideal solvent. For method B, acetonitrile is observed to
be the best solvent owing to its high dielectric constant
and good solvating capacity for π-acceptors. However,
water is not suitable for both the methods due to limited
solubility of reagents.
Effect of heating time and temperature
The effect of time is studied by following the complete
color development at different time intervals. The results
obtained (Fig. 5) indicated that maximum absorbance is
attained at 15 min for method A and 10 min for method
B. The optimum temperature to carry out the reaction is
determined by following the absorption intensity at dif-
ferent temperatures ranging from 30–80 °C. Maximum
absorbance values are obtained at 60 °C, and the reac-
tion product remained stable for 3 h in method A. In
method B, heating at 50 °C is sufficient and the product
remained stable for 24 h.
Effect of reagent volume
For method A, the effect of different volumes of particu-
lar concentrations of DNPH and potassium hydroxide
on fixed concentration of KT is investigated. It is found
that reproducible absorbance value is obtained with
1 mL of 0.005 M DNPH and 1 mL of 2 N potassium
hydroxide. Excess addition of base is avoided because
stable results are not obtained and also the color of
blank solution remains dark for long time. For method
B, various volumes of TCNQ solutions are added to
fixed drug concentration and the results show that 2 mL
of 0.0005 M is adequate for reproducible and maximum
color absorbance.
Stoichiometry of reaction
The molar ratio of drug to reagent is analyzed by
employing Job’s method of continuous variation (House
2013). At the optimum wavelength, the composition of
KT-TCNQ reaction product is found to be 1:1. The stoi-
chiometric relationship is illustrated in Fig. 6.
Validation of methods
The developed methods are validated with respect to
linearity, accuracy and precision, specificity, limit of de-
tection, and quantification according to the guidelines
set by International Conference on Harmonization (ICH
Q2 R1 2005).
Linearity and sensitivity
The proposed methods conform to Beer’s Law, and
linear relationship (Fig. 7) in the absorbance-
concentration plot is obtained in the concentration
range of 0.50–18.50 μg mL−1 for method A and 2.00–
Fig. 4 Effect of solvent on the reaction of KT with DNPH and TCNQ
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50.00 μg mL−1 for method B. The following equations
have been obtained by the regression analysis of the linear
plot. For method A, Y = 0.0531 + 0.0564X, r = 0.9985 and
for method B, Y = 0.0112 + 0.0133X, r = 0.9992, where Y is
the absorbance and X is the concentration of drug in μg
mL−1 and r is the correlation coefficient. Various optical
and sensitivity parameters like molar absorptivity and San-
dell’s sensitivity are also computed and compiled in
Table 1. The results indicate good sensitivity of the pro-
posed methods.
Limit of detection and quantification
The detection limit (LOD) and quantification limit
(LOQ) is determined by evaluating the minimum level
at which the active ingredient can be detected and quan-
tified, respectively, with reliable accuracy and precision.
The following expression was used: LOD = 3.3 σ/s and
LOQ = 10 σ/s where σ is the standard deviation of the
values obtained by replicate determination of blank and
s is the slope of the calibration curve. The calculated
values of LOD and LOQ are summarized in Table 1.
a
b
Fig. 5 Effect of temperature on the reaction of KT with a DNPH and b TCNQ
Fig. 6 Job’s continuous variation plot of KT-TCNQ at detectable peak 842 nm
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Accuracy and precision
The accuracy and precision of proposed methods are de-
termined by intraday and interday analysis of KT at three
different concentration levels within optimized linearity
range, and each concentration was replicated five times
and presented in Table 2. The results are reported as
percentage relative error (RE %) and percentage relative
standard deviation (RSD %) which indicates the accuracy
and precision of methods, respectively. The RE % and
RSD % values thus obtained is less than 2 % which dem-
onstrates good accuracy and precision of the methods.
Specificity
The specificity or the selectivity of the proposed
methods is studied by specifically analyzing the drug in
the presence of other non-medicinal ingredients that
forms the matrix in formulation. The standard addition
method was employed to study the influence of common
excipients found in the selected pharmaceutical formula-
tion such as microcrystalline cellulose, lactose, polyethyl-
ene glycol, sodium chloride, and magnesium stearate.
Satisfactory percentage recovery values tabulated in
Table 3 indicates that the excipients did not interfere
with the determination of drug by the proposed spectro-
photometric methods.
Application to the analysis of formulation
The developed methodology is applied to the determin-
ation of KT in three different pharmaceutical formula-
tions. As can be seen from Table 3, the results of the
assay are in good accordance with the label claim. The
accuracy and reliability of the proposed assay are con-
firmed by applying the statistical tests such as Stu-
dent’s t test. It is found that experimental t-value is
smaller than the theoretical tabulated value at 95 %
confidence interval and five degrees of freedom. Ap-
preciable percentage recovery values in the range of
100.03–100.40 % and 99.90–100.03 % are obtained for
method A and method B, respectively, which strongly
suggests non-interference of pharmaceutical adjuvant
in the proposed assay.
Characterization of reaction products
FTIR spectra
The infrared spectra of the synthesized reaction prod-
ucts KT-DNPH and KT-TCNQ are depicted in Fig. 8.
The analysis of main infrared peaks of KT-DNPH and
KT-TCNQ suggests the formation of Schiff base and
charge transfer complexation, respectively. In the infra-
red (IR) spectra of KT-DNPH product, the appearance
a
b
Fig. 7 Calibration graphs of proposed methods a KT-DNPH and b KT-TCNQ
Table 1 Spectral parameters and statistical data of the
regression equation
Parameters Method A Method B
λ max (nm) 424 842
Beer’s law limits (μg mL−1) 0.50–18.50 2.00–50.00
Molar absorptivity (L mol−1 cm−1) 0.7829 × 105 0.9033 × 104
Sandell sensitivity (μg cm−2) 0.4807 × 10−2 4.1666 × 10−2
Limit of detection (μg mL−1)a 0.1579 0.3721
Limit of quantification (μg mL−1)a 0.4787 1.1278
Regression equationb Y = a + bX Y = a + bX
Intercept (a) 0.0531 0.0112
Slope (b) 0.0564 0.0133
Correlation coefficient (r) 0.9985 0.9992
aLimit of quantification and detection is calculated according to the
ICH guidelines
bY is the absorbance and X is the concentration in μg mL−1
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of strong absorption band at 1622 and 3277 cm−1 is
assigned to the stretching vibration of C=N and –NH
group, respectively, which confirms the formation of
azomethine functional group. The intense band at 1737
and 1587 cm−1 is assigned to the carboxylate ester group
and bending vibrations for N–H group in pure drug KT.
The infrared spectra of charge transfer complex KT-
TCNQ are characterized by the appearance of main
bands of both donors and acceptors but show small
shifts in both wave number values and band intensities
compared to those of reactants which give conclusive
evidence of charge transfer complexation. These shifts
could be concerned with changes in molecular symmetry
and electronic structure upon complex formation (Abeer
et al. 2013). In the IR spectrum of pure KT, the stretch-
ing C–N frequency is shifted from 1309 to 1400 cm−1 in
the CT complex, suggesting that electron transition of n
to π* occurs from C–N site of pyrrolizine moiety of KT.
The frequency of C≡N and C=C is observed at 2222 and
1543 cm−1 in free TCNQ molecule which is shifted to
2129 and 1597 cm−1 in IR graph of KT-TCNQ,
respectively. The aromatic ring of TCNQ is electron de-
ficient in nature due to the presence of four electron
withdrawing cyano groups attached to it. The electron
donation process from HUMO of the donor to LUMO
of acceptor increases the charge density on CN group of
TCNQ thus decreases the CN bond order, and hence,
lower vibrational wave number is observed after com-
plexation (Adam 2012; Adam and Refat 2014; Refat et al.
2014; Refat et al. 2015).
1H NMR spectra
The 1H NMR spectra of reaction products KT-DNPH
and KT-TCNQ are given in Fig. 9. In the spectra of KT-
DNPH, the appearance of singlet peak integrating for
one proton at δ 11.01 ppm confirms formation of azo-
methine group. Furthermore, multiplets are observed for
Schiff base product in the range δ 5.96–8.79 ppm which
is integrated for ten aromatic protons compared to seven
aromatic protons in the range δ 5.99–7.72 ppm for pure
drug. These observations strongly suggest the formation
of Schiff base product in method A. The charge transfer
interaction between donor KT and acceptor TCNQ is
also confirmed by observing the change in the intensities
and values of chemical shifts in 1H NMR spectrum of
charge transfer product. It is observed that down fiel-
ding (higher shift) of most signals occurred in the
spectrum of KT-TCNQ complex. The aromatic pro-
tons of KT exhibit proton signals integrating for
seven protons in range δ 6.00–7.72 ppm which is
shifted to δ 6.05–7.74 ppm integrating for eleven pro-
tons upon complexation with TCNQ. This up-field
shift strongly confirms the charge transfer interaction.
SEM studies
The scanning electron microscopy is routinely used
technique that reveals information about the micro-
scopic aspects of reaction products i.e., microstruc-
ture, particle size, and the surface morphology [32].
The scanning electron micrograph of the synthesized
reaction products is shown in Fig. 10. The analysis of
electron micrograph of final products of reaction
Table 2 Accuracy and precision data for the determination of KT by the proposed methods
Methods KETO taken (μg mL−1) Intraday (n = 5) Interday (n = 5)
KETO founda ± SD (μg mL−1) RE (%) RSD (%) KETO founda ± SD (μg mL−1) RE (%) RSD (%)
Method A 2.5 2.47 ± 0.02 1.20 0.81 2.51 ± 0.03 0.40 1.52
6.5 6.46 ± 0.02 0.61 0.30 6.51 ± 0.06 0.27 1.04
10.5 10.51 ± 0.05 0.09 0.48 10.47 ± 0.06 0.21 0.61
Method B 10 10.04 ± 0.08 0.40 0.79 10.01 ± 0.13 0.10 1.29
26 26.02 ± 0.12 0.07 0.46 25.88 ± 0.11 0.46 0.42
34 34.02 ± 0.12 0.05 0.35 33.82 ± 0.08 0.52 0.23
SD standard deviation, RSD relative standard deviation, RE relative error
aMean value of five determinations




Amount founda ± SD
Method A Method B
Ketorol 10 10.04 ± 0.09 9.99 ± 0.08
t testb = 0.95 t testb = 0.50
% Recc = 100.40 % Recc = 99.90
Ketorol (IM/IV) 30 30.01 ± 0.01 30.01 ± 0.03
t testb = 0.78 t testb = 0.99
% Recc = 100.03 % Recc = 100.03
Ketlur sterile
eye drops
5 5.01 ± 0.05 5.00 ± 0.06
t testb = 1.74 t testb = 0.17
% Recc = 100.20 % Recc = 100.00
aMean value of five determinations
bTheoretical t-value at 95 % confidence level is 2.78
cRecovery
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shows that they have particle size of ~100 μm and
KT-DNPH displays well-defined leaf-shaped particle
with the tendency to form clusters while KT-TCNQ
exhibits small to large rock-shaped particles. The
uniformity and similarity between the synthesized par-
ticle forms of KT reaction products indicate the pres-




Fig. 8 Infrared spectra of a KT-DNPH and b KT-TCNQ
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Fig. 9 1H NMR spectra of a KT-DNPH and b KT-TCNQ
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Conclusions
The proposed analytical methods for the determination
of KT in pure form and pharmaceutical formulation
proved to be simple, accurate, and precise compared to
the previously reported methods. The assay is rapid and
requires simple sample preparation and economical
since it depends on the commercially available labora-
tory instruments and low consumption of readily avail-
able inexpensive reagents. Furthermore, the excipients
present in the formulations gave minimal interference
with the proposed assay. These advantages permit the
successful evaluation of these methods in pharmaceut-
ical quality control, and so, it can be routinely applied to
the pharmaceutical sample without prior treatment in
the determination of KT in bulk and dosage forms. The
formation of solid reaction products of KT is confirmed
by FT-IR and 1H NMR, and features of surface morph-
ology are investigated by scanning electron microscopy.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
NBSI formulated, optimized, and validated the analytical methods and drafted
the research findings. The contribution of carefully evaluating, critical revising,
and finalization of manuscript was extended by BN. Both authors read and
approved the final manuscript.
Acknowledgements
The authors gratefully acknowledge CAD Pharma Inc., Bangalore, for giving
the drug sample. The authors would also like to thank the University Grants
Commission for the financial assistance through BSR one time grant for the
purchase of chemicals and Mangalore University for providing the required
research facilities to carry out this work.
Received: 23 September 2015 Accepted: 6 November 2015
References
Abeer AH, Foziah AS, Refat MS. Spectroscopic and thermal investigations on the
charge transfer interaction between risperidone as a schizophrenia drug with
some traditional π-acceptors: part 2. J Mol Struct. 2013;1036:464–77.
Adam AMA. Synthesis, spectroscopic, thermal and antimicrobial investigations of
charge-transfer complexes formed from the drug procaine hydrochloride
with quinol, picric acid and TCNQ. J Mol Struct. 2012;1030:26–39.
Adam AMA, Refat MS. Chemistry of drug interactions: characterization of charge-
transfer complexes of guaifenesin with various acceptors using spectroscopic
and thermal methods. Russ J Gen Chem. 2014;84:1847–56.
Arshiya F, Sayaji R, Venkateshwarlu G. Quantitative determination of drugs and
pharmaceuticals using p-chloranilic acid as reagent. Int J ChemTech Res.
2012;4:79–91.
Blais V, Zhang J, Rivest S. In altering the release of glucocorticoids, ketorolac
exacerbates the effects of systemic immune stimuli on expression of
proinflammatory genes in the brain. Endocrinology. 2002;143:4820–7.
Brown CR, Moodie JE, Dickie G, Wild VM, Smith BA, Clarke PJ, et al. Analgesic
efficacy and safety of single-dose oral and intramuscular ketorolac
tromethamine for postoperative pain. Pharmacother. 1990;10:59S–70.
Buckley MM, Brogden RN. Ketorolac: a review of its pharmacodynamic and
pharmacokinetic properties and therapeutic potentials. Drugs.
1990;39:86–109.
Dasgupta PK, Zhang G, Schulze S, Marx JN. Measurement of carbonyl
compounds as the 2,4-dinitrophenylhydrazonate anion. Reaction
mechanism and an automated measurement system. Anal Chem.
1994;66:1965–70.
Dattaray MS, Uday CN. Spectrophotometric determination of ketorolac
tromethamine in its dosage forms using 3-methyl-2-benzothiazolinone
hydrazone hydrochloride. Indian Drugs. 1997;34:608–9.
Dave JB, Vyas PJ, Patel CN. A validated stability-indicating high performance
liquid chromatographic method for moxifloxacin hydrochloride and
ketorolac tromethamine eye drops and its application in pH dependant
degradation kinetics. Chron Young Sci. 2013;4:24–31.
DeAndrade JR, Maslanka M, Maneatis T, Bynum L, Burchmore M. The use of
ketorolac in the management of postoperative pain. Orthopedics.
1994;17:157–66.
Devarajan PV, Gore SP, Chavan SV. HPTLC determination of ketorolac
tromethamine. J Pharm Biomed Anal. 2000;22:679–83.
Dubey SK, Jangala H, Venkatesh CK, Saha RN, Pasha S. New chiral reverse phase
HPLC method for enantioselective analysis of ketorolac using chiral AGP
column. J Pharm Anal. 2012;2:462–5.
House JE. Inorganic chemistry. UK: Elsevier; 2013.
ICH Q2 (R1) (2005) Validation of analytical procedures: text and methodology.
Current step 4 version parent guideline dated 27 October 1994
(complimentary guideline on methodology dated 6 November 1996
incorporated in November 2005).
Jitendra DF, Harshal PM, Rajesh YC, Vijay RP. Simultaneous spectrophotometric
estimation of ofloxacin and ketorolac tromethamine in ophthalmic dosage
form. Int J ChemTech Res. 2009;1:189–94.
Kamath BV, Shivram K, Shah AC. Determination of diclofenac sodium, famotidine
and ketorolac tromethamine by flow injection analysis using
dichloronitrophenol. J Pharm Biomed Anal. 1994;12:343–6.
Kumaraswamy G, Kumar JMR, Bhikshapathi DVRN, Venkatesh G, Spandana R. A
validated RP-HPLC method for simultaneous estimation of febuxostat and
ketorolac tromethamine in pharmaceutical formulations. J Drug Deliv Ther.
2012;2:173–6.
Litvak KM, McEvoy GK. Ketorolac, an injectable nonnarcotic analgesic. Clin Pharm.
1990;9:921–35.
Fig. 10 SEM images of a KT-DNPH and b KT-TCNQ
Ismail and Narayana Journal of Analytical Science and Technology  (2015) 6:32 Page 11 of 12
Orlandini S, Fanali S, Furlanetto S, Marras AM, Pinzauti S. Micellar electrokinetic
chromatography for the simultaneous determination of ketorolac
tromethamine and its impurities. Multivariate optimization and validation.
J Chromatogr A. 2004;1032:253–63.
Pratapareddy AJ, Chakravarthi IE. New spectrophotometric determination of
ketorolac tromethamine in bulk and pharmaceutical dosage form. Int J
Pharm Sci Res. 2012;3:4848–50.
Rajasekaran A. Spectrophotometric determination of ketorolac tromethamine in
pharmaceutical dosage forms. Eastern Pharmacist. 1995;38:165–6.
Ramzia IE, Marwa AF, Fatma-Elzhraa MK, Emad MH. Derivative and derivative ratio
spectrophotometric methods for the simultaneous determination of
moxifloxacin hydrochloride with ketorolac tromethamine and ciprofloxacin
hydrochloride with dexamethasone sodium phosphate in bulk and drop.
J Chem Pharm Res. 2013;5:155–64.
Razzaq SN, Ashfaq M, Khan IU, Mariam I. Stability indicating HPLC method for the
simultaneous determination of ofloxacin and ketorolac tromethamine in
pharmaceutical formulations. Anal Methods. 2012;4:2121–6.
Refat MS, Gobouri AA, Adam AMA, Saad HA. Novel charge-transfer complexes of
4-hexylamino-1,8-naphthalimide-labelled PAMAM dendrimer with some
acceptors: a spectrophotometric study. Phys Chem Liq. 2014;52:680–96.
Refat MS, Ismail LA, Adam AMA. Shedding light on the photostability of two
intermolecular charge-transfer complexes between highly fluorescent
bis-1,8-naphthalimide dyes and some π-acceptors: a spectroscopic study
in solution and solid states. Spectrochim Acta A. 2015;134:288–301.
Resman-Targoff BH. Ketorolac: a parenteral nonsteroidal anti-inflammatory drug.
Ann Pharmacother. 1990;24:1098–104.
Sawsan AA, Maha AM, Marwa MS. Validated spectrophotometric methods for
the determination of ketorolac tromethamine. Egypt J Anal Chem.
2013;22:114–29.
Sinha VR, Kumar RV, Singh G. Ketorolac tromethamine formulations: an overview.
Expert Opin Drug Del. 2009;6:961–75.
Squella JA, Lemus I, Sturm JC, Nunez-Vergara LJ. Voltammetric behavior of
ketorolac and its HPLC-EC determination in tablets. Analytical Letters.
1997;30:553–64.
Stanski DR, Cherry C, Bradley R, Sarnquist FH, Yee JP. Efficacy and safety of single
doses of intramuscular ketorolac tromethamine compared with meperidine
for postoperative pain. Pharmacother. 1990;10:40S–4.
Tsvetkova BG, Pencheva IP, Peikov PT. HPLC determination of ketorolac
tromethamine in tablet dosage forms. Der Pharmacia Sinica. 2012;3:400–3.
Vandana P, Shital P, Suwarna K, Rushikesh P, Smita V. Development and
validation of HPTLC method for the simultaneous analysis of gatifloxacin and
ketorolac tromethamine in eye drops. J Chem Pharm Res. 2013;5:135–41.
Yatri JB, Sandip KS, Parmeshwari JM. A validated UV spectrophotometric method
for the estimation of olopatadine and ketorolac tromethamine in ophthalmic
dosage form. Int J Pharm Sci Rev Res. 2013;20:118–20.
Submit your manuscript to a 
journal and beneﬁ t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the ﬁ eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
Ismail and Narayana Journal of Analytical Science and Technology  (2015) 6:32 Page 12 of 12
